A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

American Journal of Ophthalmology

Volumn 135, Issue 1, 2003, Pages 55-63

  Noecker, Robert S ^a   Dirks, Monte S ^b   Choplin, Neil T ^c   Bernstein, Paula ^d   Batoosingh, Amy L ^d   Whitcup, Scott M ^d,e  

^a UNIVERSITY OF ARIZONA   (United States)

^b Black Hills Regional Eye Institute   (United States)

^c San Diego   (United States)

^d ALLERGAN INC   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST; LAMOTRIGINE;

ADULT; ALLERGIC CONJUNCTIVITIS; ARTICLE; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG SAFETY; EYE BURN; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRITIS; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL EXAMINATION; MULTICENTER STUDY; OCULAR PRURITUS; PANCREATITIS; PRIORITY JOURNAL; PTOSIS; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMIDES; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LIPIDS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; SAFETY;

EID: 0037215424     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01827-5     Document Type: Article

References (17)

1. The advanced glaucoma intervention study (AGIS) 7 the relationship between control of intraocular pressure and visual field deterioration . Am J Ophthalmol. 130:2000;429-440.
2. Kass M., Heuer D., Higginbotham E., et al. The ocular hypertension treatment study a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma . Arch Ophthalmol. 120:2002;701-713.
3. Brandt J., VanDenburgh A., Chen K., Whitcup S. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP a 3-month clinical trial . Ophthalmology. 108:2001;1023-1031.
4. Sherwood M., Brandt J. 1 + 2. 6-Month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated IOP. Surv Ophthalmol. 45:(Suppl 4):2001;S361-S368.
5. Alm A., Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning a comparison with timolol. Scandinavian Latanoprost Study Group . Ophthalmology. 102:1995;1743-1752.
6. Camras C. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group . Ophthalmology. 103:1996;138-147.
7. Watson P., Stjernschantz J. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmology. 103:1996;126-137.
8. DuBiner H., Cooke D., Dirks M., et al. Efficacy and safety of bimatoprost in patients with elevated IOP a 30-day compar-ison with latanoprost . Surv Ophthalmol. 45:(Suppl 4):2001;S353-S360.
9. Gandolfi S., Simmons S., Sturm R., Chen K., VanDenburgh A. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. The Bimatoprost Study Group 3. Adv Ther. 18:2001;110-121.
10. Morikawa T., Yoshida M. A useful testing strategy in phase III trials combined test of superiority and test of equivalence . J Biopharm Stat. 5:1995;297-306.
11. Fleiss J. Statistical methods for rates and proportions. 1981;John Wiley and Sons, New York.
12. Lehmann E. Nonparametrics. Statistical methods based on ranks. 1975;Holden-Day, California.
13. Singh K., Spaeth G., Zimmerman T., Minckler D. Target pressure? Glaucomatologists' holey grail. Ophthalmology. 107:2000;629-630.
14. Mao L., Stewart W., Shields M. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am J Ophthalmol. 111:1991;51-55.
15. Nordmann J., Mertz B., Yannoulis N., et al. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension 6 month data . Am J Ophthalmol. 133:2002;1-10.
16. Simmons S., Samuelson T. Comparison of brimonidine with latanoprost in the adjunctive treatment of glaucoma Alphagan/Xalatan Study Group . Clin Ther. 22:2000;388-399.
17. Alm A., Widengard I., Kjellgren D., et al. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol. 79:1995;12-16.